Literature DB >> 8015372

Protein-DNA interactions in the promoter region of the amyloid precursor protein (APP) gene in human neocortex.

W J Lukiw1, E I Rogaev, L Wong, G Vaula, D R McLachlan, P St George Hyslop.   

Abstract

We have investigated protein-DNA interactions in the proximal promoter of the human amyloid precursor protein (APP) gene in temporal lobe neocortical nuclei isolated from control and Alzheimer disease (AD) affected brains. We report that the human APP 5' promoter sequence from -203 to +55 bp, which has been previously reported to contain essential regulatory elements for APP gene transcription, lies in a deoxyribonuclease I, micrococcal nuclease- and restriction endonuclease-sensitive, G+C-rich nucleosome-free gap flanked both 5' and 3' by typical nucleosome structures. As analyzed by electrophoretic mobility shift assay, this extended internucleosomal linker DNA is heavily occupied by nuclear protein factors, and interacts differentially with nuclear protein extracts obtained from HeLa and human brain neocortical nuclei. This suggests that the chromatin conformation of the APP gene promoter may vary in different cell types, and may correlate with differences in APP gene expression. Human recombinant transcription factors AP1, SP1 and TFIID (but not AP2 or brain histones H1, H2B and H4) interact with the -203 to +55 bp of the human APP promoter sequence. Only minor differences were observed in the chromatin structure of the immediate APP promoter between non-AD and AD affected neocortical nuclei, suggesting either that post-transcriptional processes, or that regulatory elements lying elsewhere in the APP gene may be important in the aberrant accumulation of the APP gene product.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8015372     DOI: 10.1016/0169-328x(94)90039-6

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  15 in total

1.  Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer's disease (AD).

Authors:  Yuhai Zhao; Walter J Lukiw
Journal:  J Nat Sci       Date:  2015-07

2.  Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes.

Authors:  W J Lukiw; R P Pelaez; J Martinez; N G Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 3.  The environment, epigenetics and amyloidogenesis.

Authors:  Jinfang Wu; Md Riyaz Basha; Nasser H Zawia
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

4.  Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice.

Authors:  A I Pogue; P Dua; J M Hill; W J Lukiw
Journal:  J Inorg Biochem       Date:  2015-07-20       Impact factor: 4.155

5.  Infantile exposure to lead and late-age cognitive decline: relevance to AD.

Authors:  Syed Waseem Bihaqi; Azadeh Bahmani; Gehad M Subaiea; Nasser H Zawia
Journal:  Alzheimers Dement       Date:  2013-07-15       Impact factor: 21.566

6.  Co-localization and distribution of cerebral APP and SP1 and its relationship to amyloidogenesis.

Authors:  Brian Brock; Riyaz Basha; Katie DiPalma; Amy Anderson; G Jean Harry; Deborah C Rice; Bryan Maloney; Debomoy K Lahiri; Nasser H Zawia
Journal:  J Alzheimers Dis       Date:  2008-02       Impact factor: 4.472

7.  AP-2 participates in the transcriptional control of the amyloid precursor protein (APP) gene in oral squamous cell carcinoma.

Authors:  Matthew J Provenzano; Lei Yu; Michael J Hitchler; Matthew P Fitzgerald; Robert A Robinson; Sigrid Wayne; Mark Ver Meer; Frederick E Domann
Journal:  Exp Mol Pathol       Date:  2007-06-26       Impact factor: 3.362

8.  Transcription factor Sp1 inhibition, memory, and cytokines in a mouse model of Alzheimer's disease.

Authors:  Bruce A Citron; Jessica N Saykally; Chuanhai Cao; John S Dennis; Melissa Runfeldt; Gary W Arendash
Journal:  Am J Neurodegener Dis       Date:  2015-12-28

Review 9.  Epigenetics, oxidative stress, and Alzheimer disease.

Authors:  Nasser H Zawia; Debomoy K Lahiri; Fernando Cardozo-Pelaez
Journal:  Free Radic Biol Med       Date:  2009-02-23       Impact factor: 7.376

10.  PuF, an antimetastatic and developmental signaling protein, interacts with the Alzheimer's amyloid-β precursor protein via a tissue-specific proximal regulatory element (PRE).

Authors:  Debomoy K Lahiri; Bryan Maloney; Jack T Rogers; Yuan-Wen Ge
Journal:  BMC Genomics       Date:  2013-01-31       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.